Japanese Life Sciences Stock News

TSE:3923
TSE:3923Software

Rakus (TSE:3923) Q3 Earnings Growth Tests Views On Premium P/E Valuation

Rakus (TSE:3923) has put fresh numbers on the table for Q3 2026, with revenue of ¥15.5b and basic EPS of ¥9.11, set against trailing 12 month EPS of ¥33.24 that sits on revenue of ¥57.7b. The company has seen quarterly revenue move from ¥12.6b in Q3 2025 and ¥13.4b in Q4 2025 to ¥14.1b in Q1 2026, ¥14.7b in Q2 2026 and now ¥15.5b in Q3 2026. Over the same stretch, basic EPS has moved from ¥5.41 to ¥6.66, ¥9.79, ¥7.69 and ¥9.11, giving investors a clear line of sight on how profitability is...
TSE:6871
TSE:6871Semiconductor

Micronics Japan (TSE:6871) Valuation After Higher Dividend Proposal And New Earnings Guidance

Dividend proposal and fresh guidance set the stage Micronics Japan (TSE:6871) has proposed an annual cash dividend of ¥95.00 per share for the fiscal year ended December 31, 2025, together with new earnings guidance for the six months to June 30, 2026. The proposed dividend compares with ¥70.00 per share a year earlier and is scheduled for payment from March 27, 2026, subject to approval at the 55th Annual General Meeting of Shareholders on March 26, 2026. At the same time, the company issued...
TSE:285A
TSE:285ASemiconductor

Kioxia Holdings (TSE:285A) Margin Decline Challenges Bullish Growth Narrative After Q3 2026 Results

Kioxia Holdings (TSE:285A) has just posted another busy quarter, with Q3 2026 revenue of ¥543.6 billion and basic EPS of ¥162.13, setting the tone for how investors will read the rest of this year. The company has seen quarterly revenue move from ¥449.0 billion in Q3 2025 to ¥543.6 billion in Q3 2026, while basic EPS shifted from ¥146.00 to ¥162.13 over the same stretch, giving you a clear sense of how the top and bottom lines have tracked together. With trailing 12 month net profit margins...